Disclosures for "Novel Biomarker for Demyelination in Diabetic Distal Symmetric Polyneuropathy: A Prospective Study")
-
Mr. Jaffry has nothing to disclose.
-
Miss Shaikh has nothing to disclose.
-
Mr. Jaffry has nothing to disclose.
-
Mr. Mandava has nothing to disclose.
-
Mr. Trivedi has nothing to disclose.
-
Mr. Ors has nothing to disclose.
-
Ms. Faiz has nothing to disclose.
-
Dr. Patel has nothing to disclose.
-
Ankit Pahwa has nothing to disclose.
-
Hongxin Chen has nothing to disclose.
-
Timothy Cunningham has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
-
Dr. Souayah has received publishing royalties from a publication relating to health care.